At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4,384 enrolled
Drug / intervention
Therapy Programming Report (TPR)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Medtronic Shock-Less Study on Physician Utilization of Shock Reduction Programming
In Brief
An observational study evaluating Therapy Programming Report (TPR) for Cardiovascular Disease. Completed, enrolled 4,384 participants across 104 sites in 12 countries.
Detailed Summary
The purpose of this clinical trial is to determine whether periodic therapy programming reports illustrating physician usage of shock reduction programming can increase utilization of recommended programming guidelines for defibrillators.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Disease
CountriesArgentina, Australia, Canada, China, Hong Kong, India, Mexico, New Zealand, Singapore, South Korea, Taiwan, United States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 2009
Enrollment StartApr 2009
Primary CompletionMar 2013
TodayJul 2026
First PostedMar 5, 2009
Enrollment StartApr 1, 2009
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 17.3 years ago
Interventions
Therapy Programming Report (TPR)behavioral
Center-specific therapy programming reports (TPRs) illustrating physician usage of shock reduction programming are provided to each center approximately 9-12 months after their first enrollment and monthly thereafter throughout the study.